NETANYA, Israel, March  30, 2026  (GLOBE NEWSWIRE) -- BiomX Inc. (NYSE:PHGE), today announced the appointment of Dr. Ehud (Udi) Levi to its newly formed Advisory Board.   Dr. Levi will support the Company in evaluating

PHGE

BiomX Adds Former Mossad Deputy to Advisory Board

BiomX Enhances Strategic Focus with New Advisory Board Member

<section class="insight" data-version="1">
  <section data-block="information">
    <h3>Information</h3>
    <p>NETANYA, Israel, March  30, 2026  (GLOBE NEWSWIRE) -- BiomX Inc. (NYSE:PHGE), today announced the appointment of Dr. Ehud (Udi) Levi to its newly formed Advisory Board.   Dr. Levi will support the Company in evaluating</p>
  </section>

  <section data-block="ai-summary-paragraph">
    <h3>AI Summary</h3>
    <p>BiomX Inc. appointed Dr. Ehud Levi to its Advisory Board, aiming to explore defense and security markets. His extensive background in intelligence and counter-terrorism positions the company well for future opportunities in emerging technologies, particularly in counter-UAS systems, likely enhancing stakeholder value and market position.</p>
  </section>

  <section data-block="ai-summary-bullets">
    <h3>Key Points</h3>
    <ul><li>BiomX appoints Dr. Ehud Levi to Advisory Board.</li><li>Dr. Levi will explore defense and security business opportunities.</li><li>He brings over 30 years of intelligence and national security experience.</li><li>Focus areas include counter-UAS technologies amid rising global threats.</li><li>Market interest in defense tech is expected to grow.</li></ul>
  </section>

  <section data-block="companies-mentioned">
    <h3>Companies Mentioned</h3>
    <ul><li><strong>BiomX Inc. (PHGE)</strong>: Strategic advisory shifts may influence future valuations.</li></ul>
  </section>

  <section data-block="category">
    <h3>Corporate Developments</h3>
    <p>This falls under &#039;Corporate Developments&#039; as a significant leadership change could redirect company strategy and investor interest towards promising sectors.</p>
  </section>

  <section data-block="market-moving">
    <h3>Market-Moving</h3>
    <ul><li>Potential partnerships in defense could unlock significant revenue streams.</li><li>Appointing Dr. Levi may boost investor confidence in PHGE&#039;s growth strategy.</li><li>Increased focus on security markets may attract institutional investments.</li><li>Emerging global threats can enhance demand for PHGE&#039;s technology solutions.</li></ul>
  </section>

  <section data-block="key-facts">
    <h3>Key Facts</h3>
    <ul><li>Dr. Ehud Levi joins BiomX&#039;s Advisory Board effective March 30, 2026.</li><li>Levi has over 30 years of experience in Israeli intelligence.</li><li>BiomX aims to expand into the security and defense markets.</li><li>The global UAV market and counter-UAS technology demand are rising.</li><li>Levi&#039;s expertise includes advising governments on military security threats.</li></ul>
  </section>

  <section data-block="trading-thesis">
    <h3>Trading Thesis</h3>
    <p>Consider buying PHGE shares for medium-term gains as strategic directions evolve.</p>
  </section>
</section>


<link type="text/css" rel="stylesheet" href="https://www.globenewswire.com/styles/gnw_nitf.css"></link><p align="left">NETANYA, Israel, March  30, 2026  (GLOBE NEWSWIRE) -- <a href="https://www.globenewswire.com/Tracker?data=TYQVsBjVd4YMUdbA8KsozRaZuvP5_xWIRUwfe_LJyAWSTAUg3-gsZMDa4hUkEOzvnsUC05xgeCBuxUmMiglTWA==" rel="nofollow" target="_blank">BiomX Inc.</a> (NYSE:<a class="ticker" href="https://www.benzinga.com/quote/PHGE">PHGE</a>), today announced the appointment of Dr. Ehud (Udi) Levi to its newly formed Advisory Board. </p>  <p align="left">Dr. Levi will support the Company in evaluating and pursuing strategic alternatives and business opportunities, with an emphasis on security and defense, aerial response systems, and counter-UAS (C-UAS) technologies. This will include identifying and assessing potential partnerships, transactions, and new business directions aligned with the Company's expansion into security and defense applications.</p>  <p align="left">Dr. Levi brings more than three decades of experience in Israeli intelligence and national security. He served in Unit 8200 of the Israel Defense Forces and later as Head of the Counter-Terror Finance Office in the Israeli Prime Minister's Office, where he led efforts to identify, track, and disrupt illicit financial networks supporting terrorist organizations, including <a href="https://www.globenewswire.com/Tracker?data=CekTo7eIJf5jiBbt8YczYAqzHDtzUykhu6vnnMbpVMjl_74jKV3uIFQr6WrdkdtBB0jGL4wn3D7hFZxjf27ho29NJhBCaw87THUx_E7Z8awT272KAavxrOAYi7CO6xLHdwVBvU29o846dyCSBFw7EGdEeSUDZYoEMY4DVjFnlknuKmcVJOiEpw6ss_BJBE_i" rel="nofollow" target="_blank">Project Cassandra</a>. In addition, Dr. Levi coordinated Israeli intelligence efforts targeting Iran and other fundamentalist terrorist organizations, including efforts focused on terrorist financing and weapons-related programs. He also served as Deputy to the Director of the Mossad, under the late Meir Dagan, and holds a doctorate in Middle Eastern studies from Ben Gurion University, with a focus on fundamentalist terrorist organizations.</p>  <p align="left">Following his retirement from government service in 2016, Dr. Levi led large-scale asset tracking and financial intelligence projects and has served as a special advisor to governments, financial institutions, and international corporations. He has advised governments on emerging military threats, specifically unmanned systems and counter-UAS applications in the conflict in Ukraine, as well as anti-money laundering and terrorist financing.</p>  <p align="left">"Unmanned systems are rapidly reshaping the global security landscape, with low-cost, high-impact UAV capabilities now widely accessible across multiple regions and actors," said Michael Oster, CEO of BiomX. "This includes the increasing use of UAVs by Iran and its proxies, such as Hezbollah, as well as their widespread deployment in active conflict zones like Ukraine. These threats are evolving, and here to stay. Dr. Levi's experience operating at the intersection of intelligence, financial systems, and asymmetric threats will be valuable as we evaluate strategic opportunities in defense and counter-UAS technologies."</p>  <p align="left">"The intersection of intelligence, technology, and national security is generating real opportunity for companies willing to move decisively," said Dr. Levi. "This is true regarding counter-UAS, defense systems, and the broader security infrastructure that governments and institutions urgently need. Having worked across these domains for over three decades, I look forward to supporting BiomX as it evaluates how to position itself in this environment."</p>  <p align="left">Dr. Levi will serve as the initial member of BiomX's newly created Advisory Board. His compensation will be aligned with the Company's existing incentive plan.</p>  <p align="left"><strong>Forward-Looking Statements</strong></p>  <p align="left">This press release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Words such as "expects," "intends," "plans," "believes," "seeks," "estimates," "may," "will," "should," "anticipates," and similar expressions are intended to identify forward-looking statements. </p>  <p align="left">These statements include, but are not limited to, statements regarding the Company's strategic direction, including potential expansion into security and defense-related technologies, potential business opportunities, and the expected contributions of Dr. Levi. Forward-looking statements are based on current expectations and assumptions that are subject to risks and uncertainties, which could cause actual results to differ materially. </p>  <p align="left">These risks and uncertainties are described in the Company's filings with the Securities and Exchange Commission. BiomX undertakes no obligation to update these statements except as required by law.</p> <img alt="" class="__GNW8366DE3E__IMG" src="https://www.globenewswire.com/newsroom/ti?nf=OTY4MDcxNyM3NTEwMDE0IzIzMTAzMjE="></img> <br></br><img alt="" src="https://ml.globenewswire.com/media/ZWYwNTY2NzctM2VlNS00MjcxLWIyZGQtZDhjMjMwZjkyZjJlLTEzMjE4NzEtMjAyNi0wMy0zMC1lbg==/tiny/BiomX.png" referrerpolicy="no-referrer-when-downgrade"></img><pre>Contact
Yair Ohayon
yairo@biomx.com</pre>

BiomX Inc. appointed Dr. Ehud Levi to its Advisory Board, aiming to explore defense and security markets. His extensive background in intelligence and counter-terrorism positions the company well for future opportunities in emerging technologies, particularly in counter-UAS systems, likely enhancing stakeholder value and market position.

BiomX Adds Former Mossad Deputy to Advisory Board

AI Summary

Sentiment Rationale

Trading Thesis

Market-Moving

Key Facts

Companies Mentioned

Corporate Developments

Related News